Plasminogen activator activity in clonogenic cell populations separated from a murine fibrosarcoma
- PMID: 2920477
- DOI: 10.1007/BF01787027
Plasminogen activator activity in clonogenic cell populations separated from a murine fibrosarcoma
Abstract
Tumor cells from a murine fibrosarcoma (FSa) produce plasminogen activator (PA), a protease that converts the zymogen plasminogen into the trypsin-like enzyme plasmin. Several studies indicate that tumor cell invasion is accompanied by proteolysis and that PA, generated by highly malignant cells, is by far the most ubiquitous protease associated with malignant transformation. Subpopulations of FSa cells were isolated by using density gradient centrifugation and the ability of these populations to form lung colonies was compared with their associated levels of PA production. Five populations of cells from a murine fibrosarcoma were separated in continuous gradients of Renografin in the density range 1.05-1.18 g/cm2. The PA activities of an unseparated control cell lysate and cell lysates of the five separated populations were determined by using [125I]fibrin as a substrate in a reaction between cell lysate and plasminogen. The assay was based on the release of digested [125I]fibrin from the surface of Petri dishes into the supernatant solution, and the results were expressed as a percentage of the total radioactivity. The cell populations collected at densities of 1.05 and 1.09 (B1, B2) were the more clonogenic with relative clonogenic efficiencies of 2.6 and 3.3 times that of the unseparated tumor population, respectively. Analysis for PA demonstrated that enzyme formation was restricted mostly to these two populations. Cells from populations 4 and 5 did not secrete increased amounts of PA and had reduced clonogenic efficiencies compared with the unseparated FSa control population. These results are consistent with the hypothesis that PA activity is correlated with the clonogenicity of tumor subpopulations isolated from a heterogeneous and complex tumor system such as the FSa.
Similar articles
-
Measurement of plasminogen activator activity from human fibrosarcoma cells by a new microassay.Int J Cancer. 1987 Dec 15;40(6):823-9. doi: 10.1002/ijc.2910400620. Int J Cancer. 1987. PMID: 3692627
-
Clonal heterogeneity in plasminogen activator activity produced by two murine tumor cell lines.Clin Exp Metastasis. 1995 Nov;13(6):439-52. doi: 10.1007/BF00118183. Clin Exp Metastasis. 1995. PMID: 7586802
-
Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.Cancer Res. 1986 Apr;46(4 Pt 1):1788-94. Cancer Res. 1986. PMID: 3081257
-
Fibrin-specific thrombolytic agents.Schweiz Med Wochenschr. 1987 Nov 14;117(46):1791-8. Schweiz Med Wochenschr. 1987. PMID: 3122317 Review.
-
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.Dan Med Bull. 1993 Sep;40(4):383-408. Dan Med Bull. 1993. PMID: 8222763 Review.
Cited by
-
Tumor progression: potential role of unstable genomic changes.Cancer Metastasis Rev. 1990 Sep;9(2):137-47. doi: 10.1007/BF00046340. Cancer Metastasis Rev. 1990. PMID: 2253313 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources